{
    "clinical_study": {
        "@rank": "107593", 
        "acronym": "MyDAKI-01", 
        "brief_summary": {
            "textblock": "The purpose of this study is to be able to better describe the incidence, timing and\n      severity of myocardial dysfunction and acute kidney injury (AKI) following a documented\n      respiratory viral illness (RSV, adenovirus, metapneumovirus, parainfluenza, influenza, etc.)\n      in pediatric patients."
        }, 
        "brief_title": "Viral Illness in Pediatric Critical Care: Incidence Timing & Severity of Associated Heart Dysfunction & Acute Kidney Injury", 
        "completion_date": {
            "#text": "July 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Heart Failure", 
            "Acute Kidney Injury"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Heart Failure", 
                "Acute Kidney Injury", 
                "Virus Diseases", 
                "Wounds and Injuries"
            ]
        }, 
        "detailed_description": {
            "textblock": "This is a single-centre, prospective and retrospective, descriptive data-collection pilot\n      study.\n\n      Prospective Data Collection:\n\n      All pediatric patients who are less than 18 years with a confirmed positive respiratory\n      viral swab will be invited to participate.\n\n      Retrospective Data Collection:\n\n      The retrospective portion of this study will examine a 5 year period prior to the start of\n      enrollment for the prospective study, with the intention to include all pediatric patients\n      who are less than 18 years with a confirmed positive respiratory viral swab and admitted\n      into the local hospital's PICU."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. The parent or legal guardian of the pediatric subject must sign the Consent Form for\n             participants in the prospective portion of the study.\n\n          2. The subject must be no greater than 18 years of age, at the time of consent.\n\n          3. The subject must be admitted to the local hospital.\n\n          4. The subject must have a confirmed positive respiratory viral swab.\n\n          5. An arterial or venous line must be in place for blood draws for participants in the\n             prospective portion of the study.\n\n        Exclusion Criteria:\n\n          1. The parent or legal guardian of the pediatric subject is unavailable or unwilling to\n             sign the Consent Form for participants in the prospective portion of the study.\n\n          2. The subject has had previous kidney injury or myocardial dysfunction prior to\n             positive respiratory viral swab.\n\n          3. The subject has any previous problems (prior to positive respiratory viral swab) with\n             their heart or kidneys that could compromise the results, in the opinion of the\n             Investigator."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "18 Years", 
            "minimum_age": "N/A", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Pediatric subjects admitted to the local hospital with a confirmed positive respiratory\n        viral swab."
            }
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 14, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01924663", 
            "org_study_id": "MyDAKI-01"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Heart Failure", 
            "Acute Kidney Injury", 
            "Myocardial Dysfunction", 
            "Pediatric Critical Care", 
            "Pediatric Intensive Care Units", 
            "Respiratory Virus"
        ], 
        "lastchanged_date": "February 4, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Saskatoon", 
                    "country": "Canada", 
                    "state": "Saskatchewan", 
                    "zip": "S7N 0W8"
                }, 
                "name": "Royal University Hospital"
            }, 
            "investigator": [
                {
                    "last_name": "Tanya Holt, MD FRCPC", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "William Bingham, MD FRCPC", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Ashok Kakadekar, MD FRCPC", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Canada"
        }, 
        "number_of_groups": "1", 
        "official_title": "Viral Illness in the Pediatric Critical Care Setting: the Incidence, Timing and Severity of Associated Myocardial Dysfunction and Acute Kidney Injury.", 
        "overall_contact": {
            "email": "tanya.holt@usask.ca", 
            "last_name": "Tanya Holt, M.D.", 
            "phone": "(306) 966-8125"
        }, 
        "overall_official": {
            "affiliation": "University of Saskatchewan", 
            "last_name": "Tanya Holt, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Canada: Ethics Review Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Myocardial dysfunction, as defined by a low ejection fraction on an Echocardiogram.", 
                "safety_issue": "Yes", 
                "time_frame": "up to 7 days"
            }, 
            {
                "measure": "Acute Kidney Injury (AKI) as defined by the meeting of the pediatric RIFLE criteria.", 
                "safety_issue": "Yes", 
                "time_frame": "up to 7 days"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01924663"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "University of Saskatchewan", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Saskatchewan", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Observational Model: Case-Only", 
        "study_type": "Observational", 
        "verification_date": "November 2013"
    }
}